EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Involvement of pentraxin‐3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats

Siluleko A Mkhize iD, Ashmeetha Manilall iD, Lebogang Mokotedi iD, Sule Gunter, Frederic S Michel

Physiological Reports · 2024

DOI: 10.14814/phy2.70086 ↗

At a glance

Journal article in Physiological Reports, 2024. Written by Siluleko A Mkhize and 4 co-authors. Institution: Integrated Molecular Physiology Research Initiative, Faculty of Health Sciences, School of Physiology, University of the Witwatersrand, Johannesburg,…. Major MEDLINE topics: C-Reactive Protein, Hypertension, Hypertrophy, Left Ventricular, Serum Amyloid P-Component. Cited 1 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Research Foundation, Wits Faculty of Health Science Individual grant.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hypertension drives the development of concentric left ventricular hypertrophy (LVH). However, the relative contribution of pentraxin‐3 (PTX‐3), a novel marker for inflammatory cardiovascular disease, in the hypertrophic response to pressure overload has not been adequately elucidated. We investigated the role of PTX‐3 in the development of LVH in spontaneously hypertensive rats (SHR), untreated and treated with either captopril (an ACE inhibitor) or hydralazine (a non‐specific vasodilator). Three‐month‐old SHR received either 20 mg/kg/day hydralazine (SHR + H, n = 6), 40 mg/kg/day captopril (SHR + C, n = 6), or plain gelatine cubes (untreated SHR, n = 7) orally for 4 months. Wistar Kyoto rats (WKY, n = 7) were used as the normotensive controls. Blood pressure (BP) was measured using the tail‐cuff method. Cardiac geometry and function were determined using M‐mode echocardiography. Circulating concentrations of inflammatory markers were measured in plasma by ELISA. LV fibrosis and cardiomyocyte width were assessed by histology. Relative mRNA expression of PTX‐3 was determined in the LV by RT‐PCR. Untreated SHR exhibited greater systolic BP and relative wall thickness (RWT) compared to WKY. Captopril and hydralazine normalized BP but only captopril reversed RWT in SHR. Circulating PTX‐3 and VCAM‐1 levels were elevated in untreated SHR and reduced with captopril and hydralazine. Circulating PTX‐3 was positively associated with systolic BP but lacked independent relations with indices of LVH. LV relative mRNA expression of PTX‐3 was similar between the groups. PTX‐3 may not be involved in the development of LVH in SHR, but plausibly reflects the localized inflammatory milieu associated with hypertension.

Subjects

MeSH terms (MEDLINE)

C-Reactive ProteinHypertensionHypertrophy, Left VentricularSerum Amyloid P-ComponentAnimalsMaleRatsAntihypertensive AgentsBlood PressureCaptoprilHydralazineRats, Inbred SHRRats, Inbred WKYPentraxins

Author keywords

hypertensioninflammationleft ventricular hypertrophypentraxin‐3vascular cell adhesion molecule‐1

Substances

Antihypertensive AgentsC-Reactive ProteinCaptoprilHydralazineSerum Amyloid P-ComponentPentraxins

Authors and institutions

  • Integrated Molecular Physiology Research Initiative, Faculty of Health Sciences, School of Physiology, University of the Witwatersrand, Johannesburg, South Africa.
  • Department of Physiology, School of Medicine, Sefako Makgatho Health Sciences University, Pretoria, South Africa.
  • Department of Health Sciences and Medicine, Bond University, Gold Coast, Queensland, Australia.

ORCID profiles: Siluleko A Mkhize, Ashmeetha Manilall, Lebogang Mokotedi

Funding

  • National Research Foundation
  • Wits Faculty of Health Science Individual grant

Cite

APA

Mkhize, S. A., Manilall, A., Mokotedi, L., Gunter, S., & Michel, F. S. (2024). Involvement of pentraxin‐3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats. Physiological Reports. https://doi.org/10.14814/phy2.70086

Vancouver

Mkhize SA, Manilall A, Mokotedi L, Gunter S, Michel FS. Involvement of pentraxin‐3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats. Physiological Reports. 2024. doi:10.14814/phy2.70086

BibTeX
@article{Mkhize2024,
  author = {Mkhize, Siluleko A and Manilall, Ashmeetha and Mokotedi, Lebogang and Gunter, Sule and Michel, Frederic S},
  title = {Involvement of pentraxin‐3 in the development of hypertension but not left ventricular hypertrophy in male spontaneously hypertensive rats},
  journal = {Physiological Reports},
  year = {2024},
  doi = {10.14814/phy2.70086}
}
Start for free →